EMERYVILLE, CA - Dynavax Technologies Corporation (NASDAQ:DVAX), a biopharmaceutical firm valued at $1.68 billion, has entered into a material definitive agreement with West Pharmaceutical Services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback